Gene Logic To Use Affymetrix s GeneChip Arrays To Build Gene Expression Databases | GenomeWeb

GAITHERSBURG, Md.--Gene Logic will be the first company to use Affymetrix's GeneChip probe arrays to build large, commercially available gene expression database products, the companies announced last week. The collaboration with Affymetrix was first initiated by Oncormed, which was acquired by Gene Logic last year.

Stephen Push, Gene Logic's vice-president for corporate communications, told BioInform that the gene expression databases created with GeneChip probe arrays will be sold on a nonexclusive basis to pharmaceutical and biotechnology companies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.